Drug safety assessment in clinical trials: methodological challenges and opportunities
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Link
http://link.springer.com/content/pdf/10.1186/1745-6215-13-138.pdf
Reference51 articles.
1. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials. September 21, 2010, Springer, New York, 4
2. Ferner RE: Newly licensed drugs. BMJ. 1996, 313: 1157-1158. 10.1136/bmj.313.7066.1157.
3. Singh S, Loke YK, Spangler JG, Furberg CD: Risk of serious adverse cardiovascular events with Varenicline- A Systematic Review and Meta-Analysis of Randomized Controlled Trials. CMAJ. 2011, 183: 1359-1366. 10.1503/cmaj.110218.
4. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S: Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010, 121: 221-229. 10.1161/CIRCULATIONAHA.109.869008.
5. Harrison-Woolrych M, Maggo S, Tan M, Savage R, Ashton J: Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand. Drug Saf. 2012, 35: 33-43. 10.2165/11597690-000000000-00000.
Cited by 156 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Enhancing clinical drug trial monitoring with blockchain technology;Contemporary Clinical Trials;2024-11
2. Accelerating evidence synthesis for safety assessment through ClinicalTrials.gov platform: a feasibility study;BMC Medical Research Methodology;2024-07-30
3. Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial;Journal of Palliative Medicine;2024-07-24
4. Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson’s Disease;Drugs - Real World Outcomes;2024-07-02
5. Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3